289 related articles for article (PubMed ID: 16906369)
1. The clinical application of etanercept in Chinese patients with rheumatic diseases.
Chou CT
Mod Rheumatol; 2006; 16(4):206-13. PubMed ID: 16906369
[TBL] [Abstract][Full Text] [Related]
2. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
3. Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series.
Toussirot É; Houvenagel É; Goëb V; Fouache D; Martin A; Le Dantec P; Dernis E; Wendling D; Ansemant T; Berthelot JM; Bader-Meunier B; Kantelip B;
Joint Bone Spine; 2012 Oct; 79(5):457-63. PubMed ID: 22088934
[TBL] [Abstract][Full Text] [Related]
4. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
Favalli EG; Pontikaki I; Becciolini A; Biggioggero M; Ughi N; Romano M; Crotti C; Gattinara M; Gerloni V; Marchesoni A; Meroni PL
Clin Rheumatol; 2017 Aug; 36(8):1747-1755. PubMed ID: 28597133
[TBL] [Abstract][Full Text] [Related]
5. Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis.
Haberhauer G; Strehblow C; Fasching P
Wien Med Wochenschr; 2010 May; 160(9-10):220-4. PubMed ID: 20632149
[TBL] [Abstract][Full Text] [Related]
6. Better short-term clinical response to etanercept in Chinese than Caucasian patients with active ankylosing spondylitis.
Chou CT; Tsai CY; Liang TH; Chang TM; Lai CH; Wei CC; Chen KH; Lin SC; Yu CL; Liou LB; Luo SF; Lee CS; Hsue YT; Huang CM; Chen JH; Lai NS; Cheng HH; Cheng TT; Lai HM; Tsai WC; Yen JH; Lu LY; Chang CP
Mod Rheumatol; 2010 Dec; 20(6):580-7. PubMed ID: 20683633
[TBL] [Abstract][Full Text] [Related]
7. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
Cole P; Rabasseda X
Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.
Rudwaleit M; Van den Bosch F; Kron M; Kary S; Kupper H
Arthritis Res Ther; 2010; 12(3):R117. PubMed ID: 20553600
[TBL] [Abstract][Full Text] [Related]
9. Anti-TNF-alpha therapy for ankylosing spondylitis.
Son JH; Cha SW
Clin Orthop Surg; 2010 Mar; 2(1):28-33. PubMed ID: 20190998
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients.
Borrás-Blasco J; Gracia-Pérez A; Rosique-Robles JD; Casterá ME; Abad FJ
Expert Opin Biol Ther; 2014 Feb; 14(2):145-50. PubMed ID: 24359492
[TBL] [Abstract][Full Text] [Related]
11. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
[TBL] [Abstract][Full Text] [Related]
12. Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.
Fleischmann R; Iqbal I
Drugs Aging; 2007; 24(3):239-54. PubMed ID: 17362051
[TBL] [Abstract][Full Text] [Related]
13. [Biologicals in the treatment of rheumatic diseases].
Scherer HU; Burmester GR
Dtsch Med Wochenschr; 2006 Oct; 131(41):2279-85. PubMed ID: 17036270
[No Abstract] [Full Text] [Related]
14. Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial.
Ruwaard J; L' Ami MJ; Kneepkens EL; Krieckaert C; Nurmohamed MT; Hooijberg F; van Kuijk A; van Denderen JC; Burgemeister L; Rispens T; Boers M; Wolbink GJ
Scand J Rheumatol; 2023 Mar; 52(2):129-136. PubMed ID: 35234569
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.
Burmester GR; Panaccione R; Gordon KB; McIlraith MJ; Lacerda AP
Ann Rheum Dis; 2013 Apr; 72(4):517-24. PubMed ID: 22562972
[TBL] [Abstract][Full Text] [Related]
16. Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen.
Borrás-Blasco J; Gracia-Pérez A; Casterá MD; Rosique-Robles JD; Abad J
Expert Opin Biol Ther; 2013 Aug; 13(8):1103-8. PubMed ID: 23675687
[TBL] [Abstract][Full Text] [Related]
17. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept.
Aghdashi MA; Khadir M; Dinparasti-Saleh R
Curr Rheumatol Rev; 2020; 16(1):61-66. PubMed ID: 31057111
[TBL] [Abstract][Full Text] [Related]
18. Long term safety of etanercept in elderly subjects with rheumatic diseases.
Fleischmann R; Baumgartner SW; Weisman MH; Liu T; White B; Peloso P
Ann Rheum Dis; 2006 Mar; 65(3):379-84. PubMed ID: 16150792
[TBL] [Abstract][Full Text] [Related]
19. Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.
Arends S; Brouwer E; van der Veer E; Groen H; Leijsma MK; Houtman PM; Th A Jansen TL; Kallenberg CG; Spoorenberg A
Arthritis Res Ther; 2011 Jun; 13(3):R94. PubMed ID: 21689401
[TBL] [Abstract][Full Text] [Related]
20. Improvement of active rheumatoid arthritis after etanercept injection: a single-center experience.
Su KY; Lee HT; Chou CT; Tsai ST; Chen WS; Tsai CY
J Chin Med Assoc; 2009 Nov; 72(11):581-7. PubMed ID: 19948435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
